ArticleBioinformation2026
Anemia of chronic disease: Evaluating iron markers and bone marrow findings.
Article in Bioinformation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Anemia of chronic disease (ACD) is a common condition associated with chronic inflammation, characterized by disordered iron metabolism and impaired erythropoiesis. This study evaluated iron metabolism markers and correlated them with bone marrow iron stores in 100 patients with anemia in chronic disease settings. Parameters including serum iron, ferritin, total iron-binding capacity (TIBC), transferrin saturation (TSAT) and soluble transferrin receptor (sTfR) were analyzed alongside bone marrow iron grading using Perls' Prussian blue staining. Most patients demonstrated low serum iron and TSAT with normal to elevated ferritin levels, while increased sTfR in some cases suggested coexisting iron deficiency. Data shows that integrating serum ferritin and sTfR with bone marrow iron grading provides a more reliable framework for distinguishing anemia of chronic disease from coexisting iron deficiency, supporting a dual biochemical-morphological approach over single-marker evaluation in routine clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.